These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 29891648)

  • 21. Apigenin-induced HIF-1α inhibitory effect improves abnormal glucolipid metabolism in AngⅡ/hypoxia-stimulated or HIF-1α-overexpressed H9c2 cells.
    Zhu ZY; Wang F; Jia CH; Xie ML
    Phytomedicine; 2019 Sep; 62():152713. PubMed ID: 31078968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HTR2A promotes the development of cardiac hypertrophy by activating PI3K-PDK1-AKT-mTOR signaling.
    Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K
    Cell Stress Chaperones; 2020 Nov; 25(6):899-908. PubMed ID: 32519137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia inducible factor-1 improves the negative functional effects of natriuretic peptide and nitric oxide signaling in hypertrophic cardiac myocytes.
    Tan T; Scholz PM; Weiss HR
    Life Sci; 2010 Jul; 87(1-2):9-16. PubMed ID: 20470788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia-induced mitogenic factor has antiapoptotic action and is upregulated in the developing lung: coexpression with hypoxia-inducible factor-2alpha.
    Wagner KF; Hellberg AK; Balenger S; Depping R; Dodd-O J; Johns RA; Li D
    Am J Respir Cell Mol Biol; 2004 Sep; 31(3):276-82. PubMed ID: 15117738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysferlin Enables Tubular Membrane Proliferation in Cardiac Hypertrophy.
    Paulke NJ; Fleischhacker C; Wegener JB; Riedemann GC; Cretu C; Mushtaq M; Zaremba N; Möbius W; Zühlke Y; Wedemeyer J; Liebmann L; Gorshkova AA; Kownatzki-Danger D; Wagner E; Kohl T; Wichmann C; Jahn O; Urlaub H; Toischer K; Hasenfuß G; Moser T; Preobraschenski J; Lenz C; Rog-Zielinska EA; Lehnart SE; Brandenburg S
    Circ Res; 2024 Aug; 135(5):554-574. PubMed ID: 39011635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polycystin-1 Is a Cardiomyocyte Mechanosensor That Governs L-Type Ca2+ Channel Protein Stability.
    Pedrozo Z; Criollo A; Battiprolu PK; Morales CR; Contreras-Ferrat A; Fernández C; Jiang N; Luo X; Caplan MJ; Somlo S; Rothermel BA; Gillette TG; Lavandero S; Hill JA
    Circulation; 2015 Jun; 131(24):2131-42. PubMed ID: 25888683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD38 promotes angiotensin II-induced cardiac hypertrophy.
    Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
    J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiomyocyte specific overexpression of a 37 amino acid domain of regulator of G protein signalling 2 inhibits cardiac hypertrophy and improves function in response to pressure overload in mice.
    Lee KN; Lu X; Nguyen C; Feng Q; Chidiac P
    J Mol Cell Cardiol; 2017 Jul; 108():194-202. PubMed ID: 28641980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways.
    Kang S; Chemaly ER; Hajjar RJ; Lebeche D
    J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
    Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
    Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
    Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
    J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
    Yin Z; Wang X; Zhang L; Zhou H; Wei L; Dong X
    Cardiovasc Ther; 2016 Feb; 34(1):21-9. PubMed ID: 26506219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isoproterenol-induced hypertrophy of neonatal cardiac myocytes and H9c2 cell is dependent on TRPC3-regulated Ca
    Han JW; Kang C; Kim Y; Lee MG; Kim JY
    Cell Calcium; 2020 Dec; 92():102305. PubMed ID: 33069962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRPC4α and TRPC4β Similarly Affect Neonatal Cardiomyocyte Survival during Chronic GPCR Stimulation.
    Kirschmer N; Bandleon S; von Ehrlich-Treuenstätt V; Hartmann S; Schaaf A; Lamprecht AK; Miranda-Laferte E; Langsenlehner T; Ritter O; Eder P
    PLoS One; 2016; 11(12):e0168446. PubMed ID: 27992507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
    Nakagawa H; Oberwinkler H; Nikolaev VO; Gaßner B; Umbenhauer S; Wagner H; Saito Y; Baba HA; Frantz S; Kuhn M
    Circ Heart Fail; 2014 Sep; 7(5):814-21. PubMed ID: 25027872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Facilitates the Development of Cardiac Hypertrophy.
    Tong YF; Wang Y; Ding YY; Li JM; Pan XC; Lu XL; Chen XH; Liu Y; Zhang HG
    Cell Physiol Biochem; 2017; 42(4):1645-1656. PubMed ID: 28746924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway.
    Kuwabara Y; Horie T; Baba O; Watanabe S; Nishiga M; Usami S; Izuhara M; Nakao T; Nishino T; Otsu K; Kita T; Kimura T; Ono K
    Circ Res; 2015 Jan; 116(2):279-88. PubMed ID: 25362209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
    Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
    Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. JIP3 deficiency attenuates cardiac hypertrophy by suppression of JNK pathway.
    Ma Q; Liu Y; Chen L
    Biochem Biophys Res Commun; 2018 Sep; 503(1):1-7. PubMed ID: 29604277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.